Intraoral melanoma: Long-term follow-up and implication for dental clinicians. A case report and literature review

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 96, Issue 4, 2003, Pages 404-413

  Gu, Gao Man ^a   Epstein, Joel B ^b   Morton Jr , Thomas H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIFUNGAL AGENT; CIMETIDINE; DACARBAZINE; DACTINOMYCIN; IMMUNOMODULATING AGENT; INTERLEUKIN 2; VINCRISTINE;

ANTIFUNGAL ACTIVITY; BIOPSY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL FEATURE; DENTAL CLINIC; DENTURE; FOCAL EPITHELIUM HYPERPLASIA; FOLLOW UP; HUMAN; KILLER CELL; LITERATURE; LONG TERM CARE; MELANOMA; MOUTH CANCER; MUCOSA INFLAMMATION; ORAL BIOPSY; PALATE DISEASE; POSTOPERATIVE CARE; PROGNOSIS; RADIATION SICKNESS; REVIEW; TUMOR VOLUME;

EID: 0141991093     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1079-2104(03)00320-2     Document Type: Article

References (43)

1. Kopf A.W., Rigel D.S., Friedman R.J. The rising incidence and mortality rate of malignant melanoma. J Dermatol Surg Oncol. 8:1982;760-761.
2. Rigel D.S., Kopf A.W., Friedman R.J. The rate of malignant melanoma in the United States are we making an impact? J Am Acad Dermatol. 17:1987;1050-1053.
3. Rigel D.S. Malignant melanoma incidence issues and their effect on diagnosis and treatment in the 1990s . Mayo Clin Proc. 72:1997;367-371.
4. Hicks M.J., Flaitz C.M. Oral mucosal melanoma epidemiology and pathobiology . Oral Oncol. 36:2000;152-169.
5. Ruiz-Godoy RIM, Mohar BA, Ochoa CF, Beltrán OA, Meneses GA. Melanoma de mucosa de Cabeza y Cuello; Experimencia en el Instituto National de Cancerologia. Patología 1992;30:157-61.
6. Rapini R.P., Golitz L.E., Greer R.O. Jr, Krekorian E.A., Poulson T. Primary malignant melanoma of the oral cavity. A review of 177 cases. Cancer. 55:1985;1543-1551.
7. Jackson D., Simpson H.E. Primary malignant melanoma of the oral cavity. Oral Surg Oral Med Oral Pathol. 39:1975;553-559.
8. McCaffrey T.V., Neel H.B. III, Gaffey T.A. Malignant melanoma of the oral cavity review of 10 cases . Laryngoscope. 90:1980;1329-1335.
9. Ostman J., Anneroth G., Gustafsson H., Tavelin B. Malignant oral tumours in Sweden 1960-1989 - an epidemiological study. Eur J Cancer B Oral Oncol. 31B:1995;106-112.
10. Barker B.F., Carpenter W.M., Daniels T.E., Kahn M.A., Leider A.S., Lozada-Nur F., et al. Oral mucosal melanomas the WESTOP Banff workshop proceedings . Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 83:1997;672-679.
11. Snow G.B., van der Waal I. Mucosal melanomas of the head and neck. Otolaryngol Clin North Am. 19:1986;537-547.
12. Black W.C., Wiggins C. Melanoma among southwestern American Indians. Cancer. 55:1985;2899-2902.
13. Black W.C., Goldhahn R.T. Jr, Wiggins C. Melanoma within a southwestern Hispanic population. Arch Dermatol. 123:1987;1331-1334.
14. Holmstrom M., Lund V.J. Malignant melanomas of the nasal cavity after occupational exposure to formaldehyde. Br J Ind Med. 48:1991;9-11.
15. Healy E., Rehman I., Angus B., Rees J.L. Loss of heterozygosity in sporadic primary cutaneous melanoma. Genes Chromosomes Cancer. 12:1995;152-156.
16. Kamb A., Herlyn M. Malignant melanoma. Kinzler K.W. The genetic basis of human cancer. 1997;507-518 McGraw-Hill, New York.
17. Gorsky M., Epstein J.B. Melanoma arising from the mucosal surfaces of the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 86:1998;715-719.
18. King O.H. Jr, Blankenship J.P., King W.A., Coleman S.A. The frequency of pigmented nevi in the oral cavity. Report of five cases. Oral Surg Oral Med Oral Pathol. 23:1967;82-90.
19. Umeda M., Shimada K. Primary malignant melanoma of the oral cavity - its histological classification and treatment. Br J Oral Maxillofac Surg. 32:1994;39-47.
20. Greene G.W., Hayres J.W., Dozier M., Blumberg J.M., Bernier J.L. Primary malignant melanoma of the oral melanoma. Oral Med Oral Pathol. 6:1953;1435.
21. Prasad M.L., Jungbluth A.A., Iversen K., Huvos A.G., Busam K.J. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Am J Surg Pathol. 25:2001;782-787.
22. Barrett A.W., Bennett J.H., Speight P.M. A clinicopathological and immunohistochemical analysis of primary oral mucosal melanoma. Eur J Cancer B Oral Oncol. 31B:1995;100-105.
23. Snow G.B., van der Esch E.P., van Slooten E.A. Mucosal melanomas of the head and neck. Head Neck Surg. 1:1978;24-30.
24. Berthelsen A., Andersen A.P., Jensen T.S., Hansen H.S. Melanomas of the mucosa in the oral cavity and the upper respiratory passages. Cancer. 54:1984;907-912.
25. Jonasch E., Haluska F.G. Interferon in oncological practice review of interferon biology, clinical applications, and toxicities . Oncologist. 6:2001;34-55.
26. Leong S.P. Immunotherapy of malignant melanoma. Surg Clin North Am. 76:1996;1355-1381.
27. Clark D.B., Priddy R.W., Kaburda M. Primary malignant melanoma of the maxillary sinus case report and literature review . J Oral Maxillofac Surg. 47:1989;754-759.
28. Patton L.L., Brahim J.S., Baker A.R. Metastatic malignant melanoma of the oral cavity. A retrospective study. Oral Surg Oral Med Oral Pathol. 78:1994;51-56.
29. Urist M.M., Balch C.M., Soong S.J., Milton G.W., Shaw H.M., McGovern V.J., et al. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg. 200:1984;769-775.
30. Batsakis J.G., Suarez P., El-Naggar A.K. Mucosal melanomas of the head and neck. Ann Otol Rhinol Laryngol. 107:1998;626-630.
31. van der Waal R.I., Snow G.B., Karim A.B. van der Waal I. Primary malignant melanoma of the oral cavity a review of eight cases . Br Dent J. 176:1994;185-188.
32. Tanaka N., Odajimi T., Mimura M., Ogi K., Dehari H., Kimijima Y., et al. Expression of Rb, pRb2/p130, p53, and p16 proteins in malignant melanoma of oral mucosa. Oral Oncol. 37:2001;308-314.
33. Mirecka J., Korabiowska M., Schauer A. Comparative distribution of S-100 protein and antigen HMB-45 in various types of melanomas and naevi. Pol J Pathol. 46:1995;167-172.
34. Takagi M., Ishikawa G. Mori W. Primary malignant melanoma of the oral cavity in Japan. With special reference to mucosal melanosis Cancer. 34:1974;358-370.
35. Tanaka N., Amagasi T., Iwaki H., Shioda S., Takeda M., Ohashi K., et al. Oral malignant melanoma in Japan. Oral Surg Oral Med Oral Pathol. 78:1994;81-90.
36. McIlroy P. Radiation mucositis a new approach to prevention and treatment . Eur J Cancer Care (Engl). 5:1996;153-158.
37. Kostler W.J., Hejna M., Wenzel C., Zielinski C.C. Oral mucositis complicating chemotherapy and/or radiotherapy options for prevention and treatment . CA Cancer J Clin. 51:2001;290-315.
38. Plevova P. Re Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity . Oral Oncol. 35:1999;225-226.
39. Baker D.G. The radiobiological basis for tissue reactions in the oral cavity following therapeutic x-irradiation. A review. Arch Otolaryngol. 108:1982;21-24.
40. Johnson J.T. Prevention of radiation-induced mucositis. Curr Oncol Rep. 3:2001;56-58.
41. Dalakas M.C., Mock V., Hawkins M.J. Fatigue definitions, mechanisms, and paradigms for study . Semin Oncol. 25:1998;48-53.
42. Dean G.E., Spears L., Ferrell B.R., Quan W.D., Groshon S., Mitchell M.S. Fatigue in patients with cancer receiving interferon alpha. Cancer Pract. 3:1995;164-172.
43. Poland J.M. The role of Candida infections as an adverse effect upon head and neck cancer patients undergoing therapeutic radiation and the effect of antimycotic treatment. Mycoses. 32:(Suppl 2):1989;39-41.